These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21798073)

  • 21. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
    Zhang C; Tu Z; Du S; Wang Y; Wang Q
    Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
    Terada T; Ueyama J; Ukita Y; Ohta T
    Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Sakata J; Matsuda Y; Korita PV; Takamura M; Ajioka Y; Hatakeyama K
    Int J Clin Exp Pathol; 2011 Apr; 4(4):363-70. PubMed ID: 21577322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AC133 expression associated with poor prognosis in stage II colorectal cancer.
    Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
    Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.
    Jiang SY; Chou JM; Leu FJ; Hsu YY; Shih YL; Yu JC; Lee MS; Shyu RY
    World J Gastroenterol; 2005 Feb; 11(7):948-53. PubMed ID: 15742394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of snail expression in hilar cholangiocarcinoma.
    Kong D; Liang J; Li R; Liu S; Wang J; Zhang K; Chen D
    Braz J Med Biol Res; 2012 Jul; 45(7):617-24. PubMed ID: 22570087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis.
    Xu P; Huang Q; Xie F; Xu XL; Shao F
    Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
    Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
    Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
    Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
    BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M
    Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.
    Feng YJ; Zhang BY; Yao RY; Lu Y
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):418-23. PubMed ID: 22893470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
    Tan FL; Ooi A; Huang D; Wong JC; Qian CN; Chao C; Ooi L; Tan YM; Chung A; Cheow PC; Zhang Z; Petillo D; Yang XJ; Teh BT
    Int J Cancer; 2010 May; 126(10):2353-61. PubMed ID: 19816939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.